Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Parks

Showing results (221-230 of 229) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 229 results.
Cell|June 6, 1986
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDSB R Starcich, B H Hahn, G M Shaw, et al.
Science (New York, N.Y.)|June 20, 1986
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDSB H Hahn, G M Shaw, M E Taylor, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-NXiaowen Liu, Laurel A Lagenaur, David A Simpson, et al.
Medrxiv : the Preprint Server for Health Sciences|September 3, 2025
Microbiota effects and predictors of Lactobacillus crispatus colonization after treatment with a vaginal live biotherapeutic: results from a randomized, double-blinded, placebo-controlled trialSeth M Bloom, Laura Symul, Joseph Elsherbini, et al.
Physical Review Letters|February 3, 2004
Spatial uniformity of laser-accelerated ultrahigh-current MeV electron propagation in metals and insulatorsJ Fuchs, T E Cowan, P Audebert, et al.
Cell Host & Microbe|March 28, 2026
Vaginal microbiota impacts of a Lactobacillus crispatus live biotherapeutic and predictors of colonization in randomized controlled trialSeth M Bloom, Laura Symul, Joseph Elsherbini, et al.
Biomedical Mass Spectrometry|April 1, 1980
Gas chromatography mass spectrometry computer analysis of volatile halogenated hydrocarbons in man and his environment--A multimedia environmental studyJ Barkley, J Bunch, J T Bursey, et al.
The Lancet. Microbe|April 7, 2025
Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trialAnke Hemmerling, Caroline M Mitchell, Suuba Demby, et al.
Nature Medicine|June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trialHedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Pageof 23

Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Cell|June 6, 1986
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDSB R Starcich, B H Hahn, G M Shaw, et al.
Science (New York, N.Y.)|June 20, 1986
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDSB H Hahn, G M Shaw, M E Taylor, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-NXiaowen Liu, Laurel A Lagenaur, David A Simpson, et al.
Medrxiv : the Preprint Server for Health Sciences|September 3, 2025
Microbiota effects and predictors of Lactobacillus crispatus colonization after treatment with a vaginal live biotherapeutic: results from a randomized, double-blinded, placebo-controlled trialSeth M Bloom, Laura Symul, Joseph Elsherbini, et al.
Physical Review Letters|February 3, 2004
Spatial uniformity of laser-accelerated ultrahigh-current MeV electron propagation in metals and insulatorsJ Fuchs, T E Cowan, P Audebert, et al.
Cell Host & Microbe|March 28, 2026
Vaginal microbiota impacts of a Lactobacillus crispatus live biotherapeutic and predictors of colonization in randomized controlled trialSeth M Bloom, Laura Symul, Joseph Elsherbini, et al.
Biomedical Mass Spectrometry|April 1, 1980
Gas chromatography mass spectrometry computer analysis of volatile halogenated hydrocarbons in man and his environment--A multimedia environmental studyJ Barkley, J Bunch, J T Bursey, et al.
The Lancet. Microbe|April 7, 2025
Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trialAnke Hemmerling, Caroline M Mitchell, Suuba Demby, et al.
Nature Medicine|June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trialHedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Pageof 23